Vascular Medicine News

W. L. Gore and Associates announced the FDA approved of its low-profile balloon expandable stent for treatment of iliac artery de novo or restenotic lesions with reference vessel diameters of 5 to 13 mm and lesion length up to 110 mm.

The dual incretin agonist tirzepatide reduced 24-hour ambulatory BP for adults with obesity-related hypertension, with the effects potentially independent of weight loss, according to data from a planned substudy of the SURMOUNT-1 trial.

AngioDynamics announced its 225 cm radial access catheter for use with the company’s atherectomy system received FDA 510(k) clearance for the treatment of peripheral artery disease.

Patients who underwent cancer surgery had an increased risk for venous thromboembolism for up to 1 year after the procedure, results from a retrospective study published in JAMA Network Open showed.

CVD remains the leading cause of pregnancy-related death in the United States, yet across the country access to cardio-obstetrics care ranges from uneven to unavailable, depending entirely on where a woman lives.

The first Friday in February is Wear Red Day. In support of increasing awareness of women’s heart health, Healio | Cardiology Today compiled a list of recent news and updates on women and CVD research.

Healio | Cardiology Today compiled a list of the top headlines in cardiology of January 2024.

Read-world data showed that more patients underwent subsequent revascularization after “CT first” evaluation for chest pain vs. other functional testing strategies, researchers reported.

For women experiencing disruptive, bothersome hot flashes, the use of menopausal hormone therapy — a one-time standard but later feared treatment option — is far from straightforward.

Salt substitutes enriched with potassium are a feasible way for people with hypertension to reduce sodium intake long term, yet clinical guidance regarding salt substitute use is lacking, according to a review published in Hypertension.